Viela Bio Inc (VIE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 130,065 | 111,649 | 131,551 | 163,575 | 200,851 |
| Marketable Securities | 237,622 | 273,534 | 293,995 | 151,255 | 113,945 |
| Receivables | 5,385 | 2,507 | N/A | N/A | 30,000 |
| Inventories | N/A | 438 | N/A | N/A | N/A |
| TOTAL | $389,299 | $403,072 | $436,807 | $321,305 | $351,038 |
| Non-Current Assets | |||||
| PPE Net | 2,786 | 1,933 | 1,517 | 1,495 | 1,499 |
| Investments And Advances | 10,792 | 2,354 | 22,832 | 20,355 | 31,415 |
| Intangibles | 18,680 | 19,151 | 19,700 | 0 | 0 |
| Other Non-Current Assets | 1,700 | 1,087 | 1,139 | 102 | 102 |
| TOTAL | $33,958 | $24,525 | $45,188 | $21,952 | $33,016 |
| Total Assets | $423,257 | $427,597 | $481,995 | $343,257 | $384,054 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,570 | 5,083 | 6,337 | 7,380 | 7,459 |
| Accrued Expenses | 16,217 | 10,752 | 29,930 | 9,527 | 9,192 |
| Other current liabilities | 24,258 | 4,638 | 4,490 | 9,929 | 12,892 |
| TOTAL | $46,045 | $20,659 | $40,941 | $26,836 | $29,543 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,384 | 0 | 0 | 0 | 0 |
| TOTAL | $1,384 | $788 | $836 | $N/A | $N/A |
| Total Liabilities | $47,429 | $21,447 | $41,777 | $26,836 | $29,543 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,950 | 54,838 | 54,725 | 50,997 | 50,991 |
| Common Shares | 55 | 55 | 54 | 51 | 51 |
| Retained earnings | -427,367 | -393,978 | -356,333 | -317,476 | -276,699 |
| Other shareholders' equity | 79 | 353 | 655 | -121 | 5 |
| TOTAL | $375,828 | $406,150 | $440,218 | $316,421 | $354,511 |
| Total Liabilities And Equity | $423,257 | $427,597 | $481,995 | $343,257 | $384,054 |